(Q46918335)

26 December 2017

title

Effects of trans-resveratrol on hypertension-induced cardiac hypertrophy using the partially nephrectomized rat model (English)

1 reference

26 December 2017

author name string

Zhaoping Liu

1

1 reference

26 December 2017

Yan Song

2

1 reference

26 December 2017

Xiaopeng Zhang

3

1 reference

26 December 2017

Zeqing Liu

4

1 reference

26 December 2017

Wenzhong Zhang

5

1 reference

26 December 2017

Weifeng Mao

6

1 reference

26 December 2017

Wei Wang

7

1 reference

26 December 2017

Wenming Cui

8

1 reference

26 December 2017

Xin Zhang

9

1 reference

26 December 2017

Xudong Jia

10

1 reference

26 December 2017

Ning Li

11

1 reference

26 December 2017

Chi Han

12

1 reference

26 December 2017

Changxing Liu

13

1 reference

26 December 2017

publication date

1 December 2005

1 reference

26 December 2017

Clinical and Experimental Pharmacology and Physiology

published in

1 reference

26 December 2017

volume

32

1 reference

26 December 2017

issue

12

1 reference

26 December 2017

page(s)

1049-1054

1 reference

26 December 2017

The molecular basis of myocardial hypertrophy and heart failure

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1681.2005.04303.X

Cardiac hypertrophy: a matter of translation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1681.2005.04303.X

Left ventricular hypertrophy: virtuous intentions, malign consequences

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1681.2005.04303.X

Endothelin system: the double-edged sword in health and disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1681.2005.04303.X

Cardiac hypertrophy in aryl hydrocarbon receptor null mice is correlated with elevated angiotensin II, endothelin-1, and mean arterial blood pressure

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1681.2005.04303.X

Nitric oxide and the enigma of cardiac hypertrophy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1681.2005.04303.X

Plant foods and herbal sources of resveratrol

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1681.2005.04303.X

Biological effects of resveratrol

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1681.2005.04303.X

Vasorelaxing activity of resveratrol and quercetin in isolated rat aorta.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1681.2005.04303.X

Resveratrol suppresses angiotensin II-induced Akt/protein kinase B and p70 S6 kinase phosphorylation and subsequent hypertrophy in rat aortic smooth muscle cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1681.2005.04303.X

Inhibitory effect of resveratrol on angiotensin II-induced cardiomyocyte hypertrophy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1681.2005.04303.X

Nitric oxide, angiotensin II, and hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1681.2005.04303.X

Molecular and cellular mechanisms of myocardial failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1681.2005.04303.X

Pathological hypertrophy and cardiac interstitium. Fibrosis and renin-angiotensin-aldosterone system

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1681.2005.04303.X

The endothelin system in pulmonary arterial hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1681.2005.04303.X

Redox-dependent signalling by angiotensin II and vascular remodelling in hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1681.2005.04303.X

Blood pressure control early in diabetes: a balance between angiotensin II and nitric oxide.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1681.2005.04303.X

Inhibition of Cyclic Strain-Induced Endothelin-1 Gene Expression by Resveratrol

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1681.2005.04303.X

Resveratrol, a phytoestrogen found in red wine. A possible explanation for the conundrum of the 'French paradox'?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1681.2005.04303.X

Antidiabetic activity of red wine polyphenolic extract, ethanol, or both in streptozotocin-treated rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1681.2005.04303.X

Red wine polyphenols prevent cardiovascular alterations in L-NAME-induced hypertension.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1681.2005.04303.X

Mechanical stress-induced cardiac hypertrophy: mechanisms and signal transduction pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1681.2005.04303.X

Myosin heavy chain expression and atrophy in rat skeletal muscle during transition from cardiac hypertrophy to heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1681.2005.04303.X

Resveratrol inhibits MAPK activity and nuclear translocation in coronary artery smooth muscle: reversal of endothelin-1 stimulatory effects

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1681.2005.04303.X

In-vivo interaction of nitric oxide and endothelin

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1681.2005.04303.X

10.1111/J.1440-1681.2005.04303.X

21 January 2018

Identifiers

DOI

1 reference

26 December 2017

1 reference

26 December 2017